112 related articles for article (PubMed ID: 7773620)
1. Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site.
Schove LT; Perez JJ; Loew GH
Bioorg Med Chem; 1994 Oct; 2(10):1029-49. PubMed ID: 7773620
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of benzodiazepine receptor affinities and anticonvulsant activities.
Villar HO; Uyeno ET; Toll L; Polgar W; Davies MF; Loew GH
Mol Pharmacol; 1989 Oct; 36(4):589-600. PubMed ID: 2554113
[TBL] [Abstract][Full Text] [Related]
3. Determinants of recognition of ligands binding to benzodiazepine receptor/GABA(A) receptors initiating sedation.
Harris DL; DeLorey TM; He X; Cook JM; Loew GH
Eur J Pharmacol; 2000 Aug; 401(3):271-87. PubMed ID: 10936485
[TBL] [Abstract][Full Text] [Related]
4. Development of a 3D pharmacophore for nonspecific ligand recognition of alpha1, alpha2, alpha3, alpha5, and alpha6 containing GABA(A)/benzodiazepine receptors.
Filizola M; Harris DL; Loew GH
Bioorg Med Chem; 2000 Jul; 8(7):1799-807. PubMed ID: 10976528
[TBL] [Abstract][Full Text] [Related]
5. Development and assessment of a 3D pharmacophore for ligand recognition of BDZR/GABAA receptors initiating the anxiolytic response.
Harris DL; Loew G
Bioorg Med Chem; 2000 Nov; 8(11):2527-38. PubMed ID: 11092538
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine-induced hyperphagia: development and assessment of a 3D pharmacophore by computational methods.
Filizola M; Harris DL; Loew GH
J Biomol Struct Dyn; 2000 Apr; 17(5):769-78. PubMed ID: 10798522
[TBL] [Abstract][Full Text] [Related]
7. Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.
Harris D; Clayton T; Cook J; Sahbaie P; Halliwell RF; Furtmüller R; Huck S; Sieghart W; DeLorey TM
J Med Chem; 2008 Jul; 51(13):3788-803. PubMed ID: 18537233
[TBL] [Abstract][Full Text] [Related]
8. Orthosteric and benzodiazepine cavities of the α
Amundarain MJ; Viso JF; Zamarreño F; Giorgetti A; Costabel M
J Biomol Struct Dyn; 2019 Apr; 37(6):1597-1615. PubMed ID: 29633901
[TBL] [Abstract][Full Text] [Related]
9. GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system.
Olsen RW; McCabe RT; Wamsley JK
J Chem Neuroanat; 1990; 3(1):59-76. PubMed ID: 2156526
[TBL] [Abstract][Full Text] [Related]
10. Proximity-accelerated chemical coupling reaction in the benzodiazepine-binding site of gamma-aminobutyric acid type A receptors: superposition of different allosteric modulators.
Tan KR; Gonthier A; Baur R; Ernst M; Goeldner M; Sigel E
J Biol Chem; 2007 Sep; 282(36):26316-25. PubMed ID: 17626010
[TBL] [Abstract][Full Text] [Related]
11. A behaviorally selective class of thiophene-containing benzodiazepine receptor ligands.
Schove LT; Chen SW; Beatty M; Maguire PA; Davies MF; Loew GH
Bioorg Med Chem; 1995 Nov; 3(11):1547-61. PubMed ID: 8634835
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different.
Hanson SM; Morlock EV; Satyshur KA; Czajkowski C
J Med Chem; 2008 Nov; 51(22):7243-52. PubMed ID: 18973287
[TBL] [Abstract][Full Text] [Related]
13. Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
Petke JD; Im HK; Im WB; Blakeman DP; Pregenzer JF; Jacobsen EJ; Hamilton BJ; Carter DB
Mol Pharmacol; 1992 Aug; 42(2):294-301. PubMed ID: 1355261
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
[TBL] [Abstract][Full Text] [Related]
15. New 1,5-benzodiazepine compounds: activity at native GABA(A) receptors.
Gatta E; Cupello A; Di Braccio M; Grossi G; Ferruzzi R; Roma G; Robello M
Neuroscience; 2010 Mar; 166(3):917-23. PubMed ID: 20096335
[TBL] [Abstract][Full Text] [Related]
16. Development of a comprehensive pharmacophore model for the benzodiazepine receptor.
Zhang W; Koehler KF; Zhang P; Cook JM
Drug Des Discov; 1995 Jan; 12(3):193-248. PubMed ID: 7662830
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of the human GABAA receptor alpha 4 subunit: identification of a unique diazepam-insensitive binding site.
Yang W; Drewe JA; Lan NC
Eur J Pharmacol; 1995 Nov; 291(3):319-25. PubMed ID: 8719416
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.
Vijayan RS; Ghoshal N
J Mol Graph Model; 2008 Oct; 27(3):286-98. PubMed ID: 18565775
[TBL] [Abstract][Full Text] [Related]
19. Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus.
Sieghart W; Schuster A
Biochem Pharmacol; 1984 Dec; 33(24):4033-8. PubMed ID: 6095867
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Huang Q; He X; Ma C; Liu R; Yu S; Dayer CA; Wenger GR; McKernan R; Cook JM
J Med Chem; 2000 Jan; 43(1):71-95. PubMed ID: 10633039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
